Continuous renal replacement therapy using a cellulose triacetate hemofilter for severe coronavirus disease [0.03%]
使用醋酸纤维素血滤器连续肾脏替代治疗重症新型冠状病毒肺炎患者
Kanako Takahashi,Hiroyuki Inoue,Masumi Kishimoto et al.
Kanako Takahashi et al.
Background: In patients with severe coronavirus disease (COVID-19), the use of acrylonitrile hemofilters can reduce cytokine concentrations. However, acrylonitrile hemofilters can easily coagulate, and the effect of hemof...
Case Reports
Renal replacement therapy. 2022;8(1):45. DOI:10.1186/s41100-022-00436-1 2022
Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis [0.03%]
日本血液透析治疗的CKD患者中COVID-19疫苗的有效性调查研究
Ayumi Yoshifuji,Masataro Toda,Munekazu Ryuzaki et al.
Ayumi Yoshifuji et al.
Background: Dialysis patients are predisposed to severe disease and have a high mortality rate in coronavirus disease 2019 (COVID-19) due to their comorbidities and immunocompromised conditions. Therefore, dialysis patien...
Retraction Note: Impact of the third wave of the COVID-19 pandemic and interventions to contain the virus on society and patients with kidney disease in Cambodia [0.03%]
撤回 notice:新冠肺炎疫情第三波对社会及柬埔寨肾病患者的影响及防控措施
Tam Nov,Toru Hyodo,Yukie Kitajima et al.
Tam Nov et al.
[This retracts the article DOI: 10.1186/s41100-021-00372-6.]. © The Author(s) 2022.
Retraction of Publication
Renal replacement therapy. 2022;8(1):27. DOI:10.1186/s41100-022-00416-5 2022
Patients with hemodialysis-induced hypoxemia had a poor prognosis of COVID-19 [0.03%]
透析引起的低氧血症患者COVID-19预后较差
Masataro Toda,Ayumi Yoshifuji,Kentaro Fujii et al.
Masataro Toda et al.
Background: We experienced that some hemodialysis (HD) patients with coronavirus disease 2019 (COVID-19) exacerbated hypoxemia during HD. Though HD-induced hypoxemia has been reported, there have been no reports of HD-ind...
Committee report: Questionnaire survey on the treatment of COVID-19 in patients receiving dialysis therapy [0.03%]
透析治疗患者的新冠肺炎治疗情况问卷调查委员会报告
Ayumi Yoshifuji,Munekazu Ryuzaki,Yuki Uehara et al.
Ayumi Yoshifuji et al.
Background: Patients with coronavirus disease 2019 (COVID-19) who receive dialysis therapy develop more severe disease and have a poorer prognosis than patients who do not. Although various data on the treatment of patien...
Remdesivir administration for Japanese COVID-19 patients undergoing maintenance hemodialysis: a retrospective observation with six case reports [0.03%]
日本COVID-19血液透析患者的瑞德西韦用药回顾性观察及6例报告
Jun Ito,Moritsugu Kimura,Tomoyuki Toya et al.
Jun Ito et al.
Background: The mortality rate of novel coronaviral disease (COVID-19) patients undergoing dialysis is considerably higher than that of patients with normal kidney function. As of August 2021, only remdesivir has been app...
Case Reports
Renal replacement therapy. 2022;8(1):14. DOI:10.1186/s41100-022-00404-9 2022
Investigation of presenteeism, physical function, and exercise habits in workers with CKD: three case reports with literature review [0.03%]
慢性肾脏病患者的带病工作、身体功能和锻炼习惯的调查：3例病例报告及文献回顾
Aki Tabata,Hiroki Yabe,Takehide Katogi et al.
Aki Tabata et al.
Management of presenteeism in the context of chronic kidney disease (CKD) is essential for disease management, ensuring the workforce's availability, and reducing health-related costs. The purpose of this case study was to investigate prese...
Case Reports
Renal replacement therapy. 2022;8(1):16. DOI:10.1186/s41100-022-00403-w 2022
Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney disease [0.03%]
晚期慢性肾脏病患者接种第二剂新冠病毒mRNA疫苗后的抗体反应比较
Masatoshi Matsunami,Tomo Suzuki,Junko Fukuda et al.
Masatoshi Matsunami et al.
Background: Currently, it is unclear whether the progression of chronic kidney disease (CKD) could be an independent predictor of antibody response after administration of a COVID-19 vaccine. This study aimed to investiga...
Low humoral immune response to the BNT162b2 vaccine against COVID-19 in nursing home residents undergoing hemodialysis: a case-control observational study [0.03%]
老年护理机构血液透析人群对BNT162b2新冠疫苗低体液免疫反应的病例对照观察研究
Mineaki Kitamura,Takahiro Takazono,Kazuko Yamamoto et al.
Mineaki Kitamura et al.
Background: Patients on hemodialysis (HD) face a high mortality risk from coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and they are therefore prioritized for...
Anna Giuliani,Luca Sgarabotto,Sabrina Milan Manani et al.
Anna Giuliani et al.
Assisted peritoneal dialysis (asPD) is a modality intended for not self-sufficient patients, mainly elderly, who are not able to perform peritoneal dialysis (PD) alone and require some help to manage the treatment. In the last decades, many...